A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 42,343 shares of ZBH stock, worth $4.68 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
42,343
Previous 41,992 0.84%
Holding current value
$4.68 Million
Previous $4.56 Million 0.29%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$104.47 - $116.17 $36,668 - $40,775
351 Added 0.84%
42,343 $4.57 Million
Q2 2024

Aug 13, 2024

SELL
$106.25 - $130.01 $241,931 - $296,032
-2,277 Reduced 5.14%
41,992 $4.56 Million
Q1 2024

May 15, 2024

BUY
$119.98 - $132.61 $552,867 - $611,066
4,608 Added 11.62%
44,269 $5.84 Million
Q4 2023

Feb 13, 2024

SELL
$102.72 - $121.7 $457,309 - $541,808
-4,452 Reduced 10.09%
39,661 $4.83 Million
Q3 2023

Nov 13, 2023

BUY
$110.76 - $143.18 $4.04 Million - $5.22 Million
36,491 Added 478.76%
44,113 $4.95 Million
Q2 2023

Aug 11, 2023

BUY
$126.43 - $145.6 $380,427 - $438,110
3,009 Added 65.23%
7,622 $1.11 Million
Q1 2023

May 10, 2023

SELL
$121.91 - $130.94 $2.13 Million - $2.29 Million
-17,484 Reduced 79.12%
4,613 $595,000
Q4 2022

Feb 13, 2023

BUY
$104.7 - $128.4 $50,046 - $61,375
478 Added 2.21%
22,097 $2.82 Million
Q3 2022

Nov 14, 2022

BUY
$101.65 - $119.27 $108,460 - $127,261
1,067 Added 5.19%
21,619 $2.26 Million
Q2 2022

Aug 12, 2022

SELL
$102.23 - $133.85 $2.34 Million - $3.07 Million
-22,903 Reduced 52.71%
20,552 $2.16 Million
Q1 2022

May 10, 2022

BUY
$108.42 - $129.58 $368,302 - $440,183
3,397 Added 8.48%
43,455 $5.56 Million
Q4 2021

Feb 11, 2022

BUY
$115.43 - $146.63 $4.62 Million - $5.87 Million
40,058 New
40,058 $5.14 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.2B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.